Posted by tensor on March 16, 2013, at 15:17:43
In reply to Re: Adding Antipsychotics Shows Risk, posted by SLS on March 16, 2013, at 8:33:10
> > My last pdoc tried to get me to try an atypical antipsychotic for depression. I was having none of it. I said "I don't want to get tardive dyskinesia" and he said "SSRIs can cause that too."
> >
> > Maybe they can, but I think the risk is much lower than for antipsychotics. Last thing I need with social anxiety is having an obvious external symptom of illness like TD. I turned him down.
>
> What are the statistics?
>
> In a partial-hospitalization setting, I have seen 50 or more people take atypical antipsychotics, none of whom developed movement abnormalities. The only cases of EPS (dyskinesia and akathisia) I encountered were in those few people who took the older, typical antipsychotics.
>
> I twice rejected the proposition by my doctor to take Zyprexa when it first came out. However, when it was prescribed to me to address a manic reaction I had to Nardil, I experienced a wonderful antidepressant effect from it. After further consideration, I decided to remain open to the idea of using atypical antipsychotics to treat depression. I started taking Abilify (aripiprazole) when it was first approved in 2002, and have been taking it ever since. I never experienced any abnormal movements. Of course, this is no guarantee that I won't develop TD later in life. Unfortunately, it seems that I do not respond well to treatment without having Abilify in my treatment regime.
>
>
> - Scott
>And the doses used for depression is often lower than for psychosis, reducing risk further.
/tensor
poster:tensor
thread:1040415
URL: http://www.dr-bob.org/babble/20130308/msgs/1040485.html